Evidence map›Paper›PMID 31001264›Full record

Trial reportFrontiers in immunology2019

Field Testing Integrated Interventions for Schistosomiasis Elimination in the People's Republic of China: Outcomes of a Multifactorial Cluster-Randomized Controlled Trial.

Gail M Williams, Yue-Sheng Li, Darren J Gray, Zheng-Yuan Zhao, Donald A Harn, Lisa M Shollenberger, Sheng-Ming Li, Xinglin Yu, Zeng Feng, Jia-Gang Guo and 9 more

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Transmission-Blocking Vaccines against Schistosomiasis Japonica.International journal of molecular sciences · 2024
    Review
  3. Review
  4. Review
  5. Schistosomiasis with a Focus on Africa.Tropical medicine and infectious disease · 2021
    Review
  6. Experimental Infection of theMicroorganisms · 2021
    Article
  7. Schistosomiasis-from immunopathology to vaccines.Seminars in immunopathology · 2020
    Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Gail M WilliamsSchool of Public Health, University of Queensland, Brisbane, QLD, Australia.
Yue-Sheng LiMolecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Darren J GraySchool of Public Health, University of Queensland, Brisbane, QLD, Australia.
Zheng-Yuan ZhaoWorld Health Organisation Collaborating Centre for Research and Control of Schistosomiasis in Lake Region, Hunan Institute of Parasitic Diseases, Yueyang, China.
Donald A HarnDepartment of Infectious Diseases, College of Veterinary Medicine and Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, United States.
Lisa M ShollenbergerDepartment of Biological Sciences, Old Dominion University, Norfolk, VA, United States.
Sheng-Ming LiWorld Health Organisation Collaborating Centre for Research and Control of Schistosomiasis in Lake Region, Hunan Institute of Parasitic Diseases, Yueyang, China.
Xinglin YuWorld Health Organisation Collaborating Centre for Research and Control of Schistosomiasis in Lake Region, Hunan Institute of Parasitic Diseases, Yueyang, China.
Zeng FengChinese Centre for Disease Control and Prevention, National Institute of Parasitic Diseases, Shanghai, China.
Jia-Gang GuoWorld Health Organisation Collaborating Centre for Research and Control of Schistosomiasis in Lake Region, Hunan Institute of Parasitic Diseases, Yueyang, China.
Jie ZhouWorld Health Organisation Collaborating Centre for Research and Control of Schistosomiasis in Lake Region, Hunan Institute of Parasitic Diseases, Yueyang, China.
Yu-Lan DongWorld Health Organisation Collaborating Centre for Research and Control of Schistosomiasis in Lake Region, Hunan Institute of Parasitic Diseases, Yueyang, China.
Yuan LiCentre of Cell and Molecular Biology Experiment, Xiangya School of Medicine, Central South University, Changsha, China.
Biao GuoSchool of Public Health, University of Queensland, Brisbane, QLD, Australia.
Patrick DriguezMolecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Marina HarvieMolecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Hong YouMolecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Allen G RossMenzies Health Institute, Griffith University, Gold Coast, QLD, Australia.
Donald P McManusMolecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite significant progress, China faces the challenge of re-emerging schistosomiasis transmission in currently controlled areas due, in part, to the presence of a range of animal reservoirs, notably water buffalo and cattle, which can harbor

Indexed as

AdolescentAdultAgedAnimalsAnthelminticsBuffaloesCattleCattle DiseasesChildChild, PreschoolChinaDouble-Blind MethodHumansMiddle AgedPraziquantelSchistosomiasis japonicaAnthelminticsPraziquantelVaccinesbovine vaccineChinaCRTmathematical modelingschistosomiasis japonica

Identifiers

PMID31001264
PMCPMC6456715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.